Literature DB >> 18390679

High-yield production of secreted active proteins by the Pseudomonas aeruginosa type III secretion system.

M Derouazi1, B Toussaint, L Quénée, O Epaulard, M Guillaume, R Marlu, B Polack.   

Abstract

The Escherichia coli system is the system of choice for recombinant protein production because it is possible to obtain a high protein yield in inexpensive media. The accumulation of protein in an insoluble form in inclusion bodies remains a major disadvantage. Use of the Pseudomonas aeruginosa type III secretion system can avoid this problem, allowing the production of soluble secreted proteins.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18390679      PMCID： PMC2423042          DOI： 10.1128/AEM.02576-07

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  20 in total

1.  Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme.

Authors:  V Monchois; C Abergel; J Sturgis; S Jeudy; J M Claverie
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

Review 2.  On the role of specific chaperones, the specific ATPase, and the proton motive force in type III secretion.

Authors:  Gottfried Wilharm; Svea Dittmann; Annika Schmid; Jürgen Heesemann
Journal:  Int J Med Microbiol       Date:  2006-11-28       Impact factor: 3.473

3.  Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector.

Authors:  Olivier Epaulard; Bertrand Toussaint; Lauriane Quenee; Madiha Derouazi; Nabil Bosco; Christian Villiers; Rozenn Le Berre; Benoit Guery; Didier Filopon; Laurence Crombez; Patrice N Marche; Benoit Polack
Journal:  Mol Ther       Date:  2006-09-27       Impact factor: 11.454

4.  Optimization of a type III secretion system-based Pseudomonas aeruginosa live vector for antigen delivery.

Authors:  Olivier Epaulard; Madiha Derouazi; Carole Margerit; Raphaël Marlu; Didier Filopon; Benoît Polack; Bertrand Toussaint
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

5.  Multicopy expression vectors carrying the lac repressor gene for regulated high-level expression of genes in Escherichia coli.

Authors:  M J Stark
Journal:  Gene       Date:  1987       Impact factor: 3.688

6.  Extracellular secretion of polypeptides using a modified Escherichia coli flagellar secretion apparatus.

Authors:  Katariina Majander; Lena Anton; Jenni Antikainen; Hannu Lång; Mirko Brummer; Timo K Korhonen; Benita Westerlund-Wikström
Journal:  Nat Biotechnol       Date:  2005-04-03       Impact factor: 54.908

Review 7.  The exoenzyme S regulon of Pseudomonas aeruginosa.

Authors:  D W Frank
Journal:  Mol Microbiol       Date:  1997-11       Impact factor: 3.501

8.  Improved secretory production of recombinant proteins by random mutagenesis of hlyB, an alpha-hemolysin transporter from Escherichia coli.

Authors:  Yasuhiro Sugamata; Toshikazu Shiba
Journal:  Appl Environ Microbiol       Date:  2005-02       Impact factor: 4.792

9.  Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxin.

Authors:  T Yasukawa; C Kanei-Ishii; T Maekawa; J Fujimoto; T Yamamoto; S Ishii
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

10.  Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa.

Authors:  S E West; H P Schweizer; C Dall; A K Sample; L J Runyen-Janecky
Journal:  Gene       Date:  1994-10-11       Impact factor: 3.688
View more
  8 in total

1.  Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.

Authors:  Daniel Aiello; John D Williams; Helena Majgier-Baranowska; Ishan Patel; Norton P Peet; Jin Huang; Stephen Lory; Terry L Bowlin; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Full virulence of Pseudomonas aeruginosa requires OprF.

Authors:  Laurène Fito-Boncompte; Annelise Chapalain; Emeline Bouffartigues; Hichem Chaker; Olivier Lesouhaitier; Gwendoline Gicquel; Alexis Bazire; Amar Madi; Nathalie Connil; Wilfried Véron; Laure Taupin; Bertrand Toussaint; Pierre Cornelis; Qing Wei; Koki Shioya; Eric Déziel; Marc G J Feuilloley; Nicole Orange; Alain Dufour; Sylvie Chevalier
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

3.  Application of a short, disordered N-terminal flagellin segment, a fully functional flagellar type III export signal, to expression of secreted proteins.

Authors:  József Dobó; János Varga; Ráchel Sajó; Barbara M Végh; Péter Gál; Péter Závodszky; Ferenc Vonderviszt
Journal:  Appl Environ Microbiol       Date:  2009-12-11       Impact factor: 4.792

4.  Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.

Authors:  Madiha Derouazi; Yan Wang; Raphaël Marlu; Olivier Epaulard; Jean-François Mayol; Nicolas Pasqual; Audrey Le Gouellec; Benoit Polack; Bertrand Toussaint
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

5.  A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.

Authors:  Audrey Le Gouëllec; Xavier Chauchet; David Laurin; Caroline Aspord; Julien Verove; Yan Wang; Charlotte Genestet; Candice Trocme; Mitra Ahmadi; Sandrine Martin; Alexis Broisat; François Cretin; Catherine Ghezzi; Benoit Polack; Joël Plumas; Bertrand Toussaint
Journal:  Mol Ther       Date:  2013-03-26       Impact factor: 11.454

6.  Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation.

Authors:  Sylvie Berthier; Minh Vu Chuong Nguyen; Athan Baillet; Marc-André Hograindleur; Marie-Hélène Paclet; Benoît Polack; Françoise Morel
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

7.  Proteins adopt functionally active conformations after type III secretion.

Authors:  Kevin James Metcalf; James Lea Bevington; Sandy Lisette Rosales; Lisa Ann Burdette; Elias Valdivia; Danielle Tullman-Ercek
Journal:  Microb Cell Fact       Date:  2016-12-23       Impact factor: 5.328

8.  Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.

Authors:  Xavier Chauchet; Dalil Hannani; Sophia Djebali; David Laurin; Benoit Polack; Jacqueline Marvel; Laurent Buffat; Bertrand Toussaint; Audrey Le Gouëllec
Journal:  Mol Ther Oncolytics       Date:  2016-12-14       Impact factor: 7.200
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.